|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1998-10-5
|
|
pubmed:abstractText |
The therapeutic outcome after (131)I first ablative treatment in patients operated on for nonmedullary differentiated thyroid carcinoma was compared after both the currently used scanning dose of 111 MBq (131)I and a scanning dose of 37 MBq (131)I.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1546-50
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9744340-Adenocarcinoma, Follicular,
pubmed-meshheading:9744340-Adult,
pubmed-meshheading:9744340-Carcinoma, Papillary,
pubmed-meshheading:9744340-Carcinoma, Papillary, Follicular,
pubmed-meshheading:9744340-Combined Modality Therapy,
pubmed-meshheading:9744340-Female,
pubmed-meshheading:9744340-Follow-Up Studies,
pubmed-meshheading:9744340-Humans,
pubmed-meshheading:9744340-Iodine Radioisotopes,
pubmed-meshheading:9744340-Male,
pubmed-meshheading:9744340-Postoperative Period,
pubmed-meshheading:9744340-Retrospective Studies,
pubmed-meshheading:9744340-Thyroglobulin,
pubmed-meshheading:9744340-Thyroid Neoplasms,
pubmed-meshheading:9744340-Thyroidectomy,
pubmed-meshheading:9744340-Time Factors,
pubmed-meshheading:9744340-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
|
|
pubmed:affiliation |
Médecine Nucléaire, Centre Paul Papin, Angers, France.
|
|
pubmed:publicationType |
Journal Article
|
